Health and Fitness Health and Fitness
Thu, June 3, 2010
[ 03:00 AM ] - Market Wire
BIOLASE to Present at the Needham Healthcare Conference in New York City
[ 01:35 AM ] - Market Wire
CIGNA Names Bert Scott to Lead U.S. Commercial Markets
[ 01:35 AM ] - Market Wire
Covidien anuncia acordo definitivo para adquirir a ev3 Inc.
[ 01:35 AM ] - Market Wire
Covidien anuncia acuerdo definitivo para adquirir ev3 Inc.
[ 01:35 AM ] - Market Wire
Somaxon Pharmaceuticals to Present at the Jefferies 2010 Global Life Sciences Conference
[ 01:35 AM ] - Market Wire
Response Genetics to Present Lung Cancer and Colo .. at the 2010 American Society of Clinical Oncology
Wed, June 2, 2010
[ 11:34 PM ] - Market Wire
NewCardio Selected to Make Presentations at 15th Annual World Congress on Heart Disease
[ 06:00 PM ] - Market Wire
Wellstar International, Inc. Announces an Update .. ults for Publication of the Duke University Study
[ 03:39 PM ] - Market Wire
A.M. Best Affirms Ratings of Humana Inc. and Its .. and Health Maintenance Organization Subsidiaries
[ 02:19 PM ] - Market Wire
Enclarity Inc. to Present Case Study With WellPoi .. ghlighting Success and Results of Better Provider
[ 01:38 PM ] - Market Wire
Dyax Corp. to Present at June 2010 Investor Conferences
[ 01:05 PM ] - Market Wire
Theravance to Present at Investor Conferences in June 2010
[ 01:00 PM ] - Market Wire
Herborium Group Commences AcnEase(R) Retail Sales
[ 11:23 AM ] - Market Wire
AmStem Corporation (Stem Cell Therapy Internation .. pening of New Operational Headquarters in San Fra
[ 10:12 AM ] - Market Wire
Constellation Software Acquires Auriga Communication Systems Ltd.
[ 09:30 AM ] - Market Wire
Medicare Administrator Issues Positive Coverage D .. Cypress Bioscience's Avise PG(SM) Testing Service
[ 07:18 AM ] - Market Wire
IDC Signs Contract with Merge Healthcare for Orthopaedics
[ 06:24 AM ] - Market Wire
Bioniche Animal Health Partners with Bayer Australia to Distribute Livestock Product Line
[ 06:00 AM ] - Market Wire
MDRNA, Inc. to Present at 9th Annual Needham Healthcare Conference
[ 05:55 AM ] - Market Wire
Radient Pharmaceuticals and Perceptive Imagineeri .. celerate Commercialization of Onko-Sure(TM) in Vi
[ 05:30 AM ] - Market Wire
AdCare Health Systems to Lease Five Nursing Homes .. Georgia, Adding $36 Million in Annualized Revenue
[ 05:30 AM ] - Market Wire
WellTek Acquires Controlling Interest of Online Social Networking Company, WellCity, Inc.
[ 05:30 AM ] - Market Wire
Corporate Profile's(R) CPreports.com Publishes Go .. Small Cap Research's Recommendation on Pluristem
[ 05:30 AM ] - Market Wire
Vicor Technologies to Present at Noble Financial 2010 Equity Conference
[ 05:26 AM ] - Market Wire
XenaCare Holdings Announces the Beginning of Its Television Campaign for Cobroxin
[ 05:00 AM ] - Market Wire
Peregrine Pharmaceuticals to Present at the Needham & Company Ninth Annual Healthcare Conference
[ 05:00 AM ] - Market Wire
SensiVida Medical Technologies, Inc. Enters Desig .. ith Wi, Inc. to Advance Development of the Compan
[ 04:30 AM ] - Market Wire
Sunesis Completes Consultative Review Process With EMA for Voreloxin in AML
[ 04:30 AM ] - Market Wire
Cities & Investors Line up to Host Sector 10's "Technology for a Safer Future" Road Show
[ 04:30 AM ] - Market Wire
Aeterna Zentaris to Present at Upcoming Needham Annual Healthcare Conference on June 10, 2010

Aeterna Zentaris to Present at Upcoming Needham Annual Healthcare Conference on June 10, 2010


Published on 2010-06-02 04:40:14 - Market Wire
  Print publication without navigation


QUÉBEC CITY, June 2 /CNW Telbec/ - Aeterna Zentaris Inc. (NASDAQ: AEZS, TSX: AEZ), ("the Company") a late-stage drug development company specialized in oncology and endocrinology, today announced that its President and CEO, Juergen Engel, Ph.D., will present a corporate overview at the upcoming 9th Annual Needham Healthcare Conference on Thursday, June 10, 2010 at 3:20 p.m. (local time) in the Henry Room of the New York Palace Hotel in New York City.

A live webcast of the presentation will be available on Aeterna Zentaris' website at [ www.aezsinc.com ] in the Investors section. A replay will also be available for a period of 30 days on the Company's website.

About Aeterna Zentaris Inc.

Aeterna Zentaris Inc. is a late-stage drug development company specialized in oncology and endocrinology. News releases and additional information are available at [ www.aezsinc.com ].

Contributing Sources